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Purpose: To correlate retinal ganglion cell (RGC) loss and optic nerve (ON) damage with the duration of acute glaucoma
attacks in a rat experimental model and to determine whether the c-Jun N-terminal kinase (JNK) inhibitor SP600125
protects against such attacks.
Methods: To model an acute glaucoma attack, rat intraocular pressure (IOP) was elevated by a controllable compression
method using pulleys and specific weights. Intraocular pressure was measured with a TonoLab® rebound tonometer.
Time-dependent ocular hypertension-induced damage was evaluated by ON morphology, retina morphology (both retina
layer thickness in cross-sections and RGC counts in Dextran tetramethylrhodamine crystals [DTMR] labeled flatmounts),
and scotopic flash electroretinography (ERG). A c-Jun N-terminal kinase (JNK) inhibitor, SP600125 (0, 1.5, 5, or 15 mg/
kg), was administered by intraperitoneal injection immediately before and after induction of ocular hypertension, then
once daily for seven days. Retinal cross-sections were measured to determine the thickness of various retinal layers and
the cell density in the ganglion cell layer (GCL). Retinal flatmounts immunolabeled with anti-rat Brn-3a primary antibody
were used to quantify RGC numbers.
Results: Elevated rat IOP induced by corneal limbus compression correlated with the different weights. Elevation to
45 mmHg for up to 7 h did not significantly affect the thicknesses of the outer nuclear layer, outer plexiform layer, or
inner nuclear layer. Amplitudes of A- and B-waves were not affected. However, elevation to 45 mmHg for up to 7 h
decreased the inner retinal thickness and caused ON damage. Most importantly, IOP elevation induced a time-dependent
RGC loss. Cell density in the GCL decreased to 70%, 62%, and 49% of that of the control after 5 h, 6 h, and 7 h, respectively,
of pressure increases. In retinal flatmount studies, labeled RGCs were reduced 56±4% (mean±SEM) versus the control
(p<0.001) after 7 h of ocular hypertension. SP600125 dose-dependently protected against ocular hypertension-induced
RGC loss. The difference in RGC density between the vehicle and SP600125-treated (15 mg/kg) groups was statistically
significant (p<0.001).
Conclusions: The correlation of inner retinal morphological changes with the duration of the application of 45 mmHg
IOP was demonstrated. Treatment with SP600125 significantly protected RGC survival against this insult. Inhibitors of
JNK may be an interesting pharmacological class for treating glaucoma.
Glaucoma  is  one  of  the  most  prevalent  causes  of
irreversible blindness in the world. It is estimated that in 2010
there were 60.5 million glaucoma patients worldwide, with
44.7  million  affected  by  primary  open  angle  glaucoma
(POAG) and 15.7 million affected by primary angle-closure
glaucoma (PACG). In the next 10 years, the total number of
PACG  patients  will  increase  to  21  million;  of  those,  5.3
million will be bilaterally blind [1]. A major risk factor for
glaucomatous damage is elevated intraocular pressure (IOP).
Retinal ganglion cells (RGCs) are the retinal components
most sensitive to IOP elevation; RGC damage is responsible
for the loss of vision in glaucoma. As a medical emergency,
the IOP of eyes with acute angle-closure glaucoma can be as
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high as 40–80 mmHg, which is believed to result in permanent
vision loss if not treated within hours of the attack [2,3]. To
induce selective damage in the inner retinal layers in animal
models,  many  studies  have  demonstrated  that  an  IOP
elevation to 30–50 mmHg is necessary. This causes selective
damage in the inner retinal layers, such as a reduced scotopic
threshold  response  (STR),  photopic  negative  response
(PhNR),  and  amplitude  of  the  pattern  electroretinogram
(PERG) [4-10].
In recent years, many animal glaucoma models have been
established  [11].  However,  almost  all  these  models  were
designed to study POAG; they either induce a low level but
prolonged IOP elevation, or generate RGC damage via insults
unrelated to pressure. These models typically do not address
the biologic changes and potential therapeutic approaches
related to acute PACG attacks. So far, the induced changes of
the inner retinal layer by transient acute moderate elevation
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864of IOP are reversible [4,12-14], which is quite different from
the irreversible functional, RGC, and inner retinal changes
seen in acute glaucoma attacks. We believe that, in addition
to moderately elevated IOP, the duration of the elevation is
another key factor in inducing damage of RGCs in an animal
study.  To  do  this,  we  induced  a  controllable,  moderate
elevation in IOP using a suture-pulley model for several hours
and monitored changes in the retina and optic nerve (ON),
which provides important insight into the pathology of an
acute PACG attack. As previously reported [13], the suture-
pulley method uses sutures that loop around and compress the
external  corneal  limbal  region  to  produce  rat  ocular
hypertension, the magnitude of which depends on the weights
attached to the ends of the suture. In the present study, we
characterized the relationship between the applied weights
and IOP elevation and the effects of ocular hypertension on
the  functional  and  morphological  changes  in  the  retina,
thereby damaging retinal components in a more selective and
controllable fashion.
We further evaluated the usefulness of this method in
assessing a potential neuroprotective agent, an inhibitor of c-
Jun N-terminal kinase (JNK). Being a member of the mitogen-
activated protein kinase family, JNK is involved in the signal
transduction  of  a  variety  of  cellular  pathways,  including
apoptosis,  inflammation,  and  carcinogenesis  [15-17].
Phosphorylation  of  JNK  and  activation  of  its  signaling
cascade have been demonstrated during RGC apoptosis in
experimental open angle glaucoma (OAG) [18]. Thus, the
blockade of this pathway by specific inhibitors may prevent
or slow the progression of RGC loss in the current PACG
attack model. SP600125 is a specific, commonly used JNK
inhibitor. It has been demonstrated to reverse neuronal cell
death in rat hippocampal Cornu Ammonis 1 (CA1) caused by
transient  brain  ischemia/reperfusion  [19,20].  In  RGC
apoptosis induced by N-Methyl-D-aspartic acid or N-Methyl-
D-aspartate (NMDA), the expression of JNK increased and
SP600125  reversed  the  apoptotic  process  [21].  In  a
preliminary report, we demonstrated that the p-JNK pathway
was activated by applying IOP of 45 mmHg over 6 h and was
blocked by SP600125 in the ganglion cell layer (GCL) [22].
Hence,  in  the  current  study,  we  investigated  whether
SP600125  would  prevent  RGC  loss  induced  by  ocular
hypertension.
METHODS
Procedures  used  in  this  investigation  conformed  to  the
Association  for  Research  in  Vision  and  Ophthalmology
(ARVO) resolution on the Use of Animals in Ophthalmic and
Vision Research and were approved by the Animal Care and
Use Committee at Shandong University School of Medicine
in  China.  Male  Wistar  rats  weighing  200–250  g  were
purchased from the Animal Center at Shandong University.
They  were  housed  in  rooms  in  which  the  temperature,
humidity,  and  lighting  (12  h:12  h  light-dark  cycle)  were
controlled and water and food were available ad libitum.
Elevation  of  IOP:  Acute  unilateral  elevated  IOP  was
induced  by  the  suture-pulley  corneal  limbal  compression
method  described  previously  [13].  Briefly,  rats  were
anesthetized  with  chloral  hydrate  (400  mg/kg,
intraperitoneal), with additional doses (60 mg/kg) given as
needed. A suture thread (1/0 to 4/0 silk) of approximately 70
cm was connected to the indicated weights at both ends. The
thread  was  then  looped  around  the  circumference  of  the
eyeball  approximately  2  mm  behind  the  limbus.
Circumferential compression of the globe symmetric to the
optical axis was produced by passing both ends of the suture
thread through a series of pulleys. The contralateral untreated
eye served as a naïve control.
To confirm continuous ocular hypertension in the eye,
IOP was measured using a TonoLab® rebound tonometer
(Colonial Medical Supply, Franconia, NH) at 5 min before
IOP elevation, then every 15 min for the first 120 min of IOP
elevation,  and  every  60  min  for  the  remaining  period  of
elevation. The elevated IOP was maintained for the indicated
duration and up to 7 h. Throughout the procedure, the mean
arterial  blood  pressure  was  monitored  and  reported  by  a
Powerlab/8SP  data  acquisition  system  (ML785;
ADInstrument, Bella Vista, Australia).
Evaluation  of  optic  nerve  damage:  Four  weeks  after
ocular hypertension, the animals were euthanized. The optic
nerve (ON) of each eye was isolated and fixed immediately
in 2% paraformaldehyde and 2.5% glutaraldehyde in a 0.1 M
cacodylate buffer (pH 7.2) overnight, placed in 1% OsO4 and
in 0.25% uranyl acetate for 2 h each, dehydrated with a series
of  acetones,  and  then  embedded  in  epoxy  resin  (Epon
Araldite; Mirivac, Halifax, NS, Canada). Next, 1 µm sections
were cut, placed on glass slides, and stained with 1% toluidine
blue  (Sigma-Aldrich,  Oakville,  ON,  Canada).  Stained
sections  were  photographed  at  10×  magnification  using  a
digital camera (Eclipse 80i; Nikon, Tokyo, Japan) and printed
so the whole nerve was visible in the field of view. The
severity of ON damage in each section was independently
graded by three masked investigators using an Optic Nerve
Damage Score (ONDS) [23], as follows: Grade 1=normal;
Grade 2=up to 20% dead and darkly stained axons with initial
gliosis; Grade 3=up to 50% dead axons with mild gliosis;
Grade 4=up to 80% dead axons with prominent gliosis; and
Grade 5=almost 100% dead axons with severe gliosis. The
mean ONDS of each ON determined by the three investigators
was reported and evaluated using statistical analysis.
Histopathology  of  retinal  cross-sections:  Eyeballs  of
euthanized rat were fixed in 4% paraformaldehyde overnight
and embedded in paraffin. Next, 4 µm thick sections were cut
across the optic papilla and stained with hematoxylin and
eosin. For quantitative analyses, sections perpendicular to the
retinal  surface  were  examined  under  a  stereomicroscope
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865(Eclipse 80i; Nikon). Thicknesses of five retinal layers were
measured in a masked fashion at three adjacent areas within
0.5 mm of the ON in the inferior peripapillary region and the
mean values were reported. The five retinal layers are: 1)
overall retinal thickness from the outer limiting membrane to
the inner limiting membrane, 2) the outer nuclear layer (ONL),
3) the outer plexiform layer (OPL), 4) the inner nuclear layer
(INL), and 5) inner retinal thickness from the inner plexiform
layer to the limiting membrane (IPL-ILM). Measurements
were performed in the same topographic region of the retina
to minimize regional anatomic variations.
Cell counts of the GCLs were performed manually across
a length of 300 µm in the same topographic region of the
retina.
Quantification  of  DTMR-labeled  RGCs  in  Retina
Flatmounts: Twenty-four hours before euthanasia, rats were
anesthetized  with  a  cocktail  of  ketamine  (75  mg/kg)  and
xylazine (5 mg/kg) and their ONs were completely transected
at  about  2  mm  behind  the  globe,  without  injuring  the
ophthalmic  artery.  Dextran  tetramethylrhodamine  crystals
(DTMR; 3000 molecular weight; Molecular Probes, Eugene,
OR) were applied at the cut end of the ON stump. Twenty-
four hours later, eyes were enucleated and fixed in a 4%
paraformaldehyde solution at 4 °C for 120 min. The retinas
were dissected from the eye cups and prepared as flatmounts,
with four radially-oriented cuts in each retina. These were then
whole-mounted on glass slides. The slides were kept in the
dark and were air dried overnight. The tissue was protected
by a cover glass with mounting medium for fluorescence
(Vector, Burlingame, CA). The DTMR-labeled RGCs were
viewed  using  a  fluorescence  microscope  (Leica)  with
rhodamine filters with maximal absorption at 560 nm. Digital
photos of each retina were taken in a low-light room using
imaging processing software (MegnaFire version 2.1). Images
of one central and one peripheral field (40× magnification;
area of each field=0.092 mm2) were captured from each of the
four retinal quadrants and were printed on a color printer. The
labeled  RGC  numbers  of  each  color  image  print  were
manually counted by an observer masked to the protocol. The
cell counts of each image were then converted into cells per
square millimeter. The cell density of each eye was calculated
by averaging the cell numbers counted from eight image areas
of each retina. Next, RGC loss in the experimental eye was
calculated as percentage of cell loss compared to the control
eye.
Brn-3a immunolabeling of RGCs in retina flatmounts:
The methods for Brn-3a immunolabeling of RGCs have been
previously described [24]. Briefly, enucleated eyeballs were
fixed in a 4% paraformaldehyde solution at 4 °C for 120 min.
A cut was made through the corneoscleral limbus. The retinas
were treated sequentially with 10%, 20%, for 60min each, and
then overnight with 30% sucrose and were then frozen and
thawed  three  times,  washed  with  PBS,  incubated  in  10%
methanol-3% H2O2-PBS for 30 min, and blocked with 2%
BSA in PBS for 2 h. Treated retinas were then incubated
overnight with monoclonal mouse anti-rat Brn-3a primary
antibody (1:50; Chemicon, Temecula, CA) and were then
incubated with horse anti-mouse IgG H+L secondary antibody
(1:200; Vecter, Burlingame, CA) for 2 h after being washed
in PBS. Retinas were incubated in Extravidin solution at room
temperature for 2 h in the dark. Following PBS washing (10
min/each), each retina was incubated using a PharMingen™
DAB substrate Kit (BD Biosciences, San Jose, CA) until the
desired  color  intensity  developed.  Stained  retinas  were
flatmounted,  microscopic  images  were  captured,  and  cell
counts were analyzed, similar to the DTMR-labeled retina
flatmounts.
Electroretinography: Scotopic ERG was used to assess
potential damage to the outer retinal layer by the elevated IOP
[13].  Briefly,  animals  were  dark-adapted  overnight  and
anesthetized. The pupils were dilated with Mydfrin™ (Alcon,
Fort Worth, TX) and corneas were anaesthetized with Alcain
(Alcon).  White  light  flashes  were  produced  by  a
photostimulator  (Model  PS22;  Grass  Instruments,  West
Warwick, RI) placed 25 cm in front of the rat’s eye. The
responses  were  recorded  and  analyzed  by  data  wave
electroretinogram collection software. Baselines of A- and B-
wave amplitudes were collected before IOP was elevated.
They were used as a comparison against the respective ERG
values  collected  at  the  indicated  time  point  after  IOP
elevation.
Administration of test articles: SP600125 (Sigma) was
dissolved in DMSO and diluted with 0.01 M PBS (154 mM
NaCl,1.9 mM NaH2PO4,8.1 mM Na2HPO4, pH 7.4) to a final
concentration of 1, 3.3, and 10 mg/ml (containing 1% DMSO).
SP600125 (1.5, 5, and 15 mg/kg) or the same volume of
vehicle was administrated intraperitoneally for a total of seven
doses, at 5 min before and immediately after IOP elevation,
and then once daily on Days 2–7 after IOP elevation.
Statistical analysis: Data are presented as mean±SEM
and were analyzed with SigmaStat 3.5 software (SPSS Inc.,
Chicago, IL). A one-way ANOVA, followed by a Dunnett’s
or Bonferroni’s test was used to compare results among three
study  groups.  A  p<0.05  was  considered  statistically
significant.
RESULTS
Intraocular pressure elevation: As previously reported, the
suture-pulley method produces rat ocular hypertension, the
magnitude of which depends on the weights attached to the
ends of the suture [13]. Therefore, when the standard weight
increases, IOP increases correspondingly. In this study, the
IOP of anesthetized rats before application of the weight was
10.5±0.2 mmHg. At 60 min after a 5 g weight was applied,
the IOP was elevated to 17.3±0.3 mmHg. Similarly, the IOP
was increased to 33.9±0.5 mmHg by 10 g, 47.0±0.1 mmHg
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866by 15 g, 61.4±0.5 mmHg by 20 g, and 79.3±0.3 mmHg by 25
g (Figure 1A). Based on these results and because of the
moderate  IOP  elevation  it  produced,  15  g  of  weight  was
chosen for the rest of the study.
When 15 g of weight was applied, the rat IOP peaked
transiently  to  53.0±1.3  mmHg  and  stabilized  at
45.0±0.1 mmHg (range from 43 to 47 mmHg) until the weight
was  removed  at  7  h  (Figure  1B).  During  the  experiment
period,  no  retinal  blanching  was  observed  by
ophthalmoscopy. However, between 1 and 2 h during the
procedure, the lens became partially cloudy, which lasted for
approximately an hour before clearing. No other anomaly was
noted. The IOP of the contralateral eye was maintained at the
baseline  level.  The  mean  arterial  blood  pressure  did  not
significantly change during the 7 h study period (data not
shown).
Optic Nerve Damage Induced by IOP Elevation: To evaluate
the ON damage in rats subjected to 1–7 h of IOP elevation
(45 mmHg) 28 days after the insult, the morphology of the
corresponding ON was assessed and an ONDS was assigned.
Representative images from all groups are shown in Figure
2A, as are two higher magnification images of an ON from a
control rat and one that had elevated IOP for 5 h. These images
show a duration-dependent injury of the ON. No significant
morphological changes were found in the ON of the 1 h, 2 h,
3 h, and 4 h groups. However, mild damage (ONDS=2±0.33,
p<0.05) in the 5 h group, an obvious injury (ONDS=2.9±0.21,
p<0.01)  in  the  6  h  group,  and  very  significant  damage
(ONDS=3.8±0.07, p<0.001) in the 7 h group was observed
(Figure 2C).
Changes in Retinal Layers Induced by IOP Elevation: At Day
28,  retinas  that  experienced  5  h,  6  h,  or  7  h  of  ocular
hypertension  were  examined  for  morphological  changes.
Representative images of treated retinas are shown in Figure
3A. These images show a duration-dependent reduction in
GCL cell density and thinning of the inner retinal layer after
7  h  of  IOP  elevation.  Quantification  of  these  changes
demonstrated that overall retinal thickness (OLM to ILM) did
not  change  significantly,  except  in  the  7  h  IOP  elevation
group. Thickness in the control group was 215.1±1.3 µm
(mean±SEM,  n=23)  and  that  in  the  7  h  group  was
174.8±3.6 µm (n=8, p<0.001). The reduction in overall retinal
thickness was mainly a result of a thinning of the inner retina
layers (IPL to ILM, Figure 3A-C). The thickness of the inner
retinal layer in the control group was 90.2±0.6 µm (n=23), and
that in the 7 h group was 63.2±2.2 µm (n=8; p<0.001). Ocular
hypertension for up to 7 h did not affect the thicknesses of the
ONL, OPL, or INL (Figure 3A,D-F). Significant cell loss in
the GCL was observed in all three experimental groups (5 h:
8.6±0.5 cells/300 µm; 6 h: 7.8±0.5 cells/300 µm; 7 h: 6.2±0.7
cells/300 µm; all p<0.001) compared to the control group
(12.4±0.4 cells/300 µm; Figure 3A, G). These changes in the
retina confirm the duration-dependent ON damages induced
by elevated IOP.
Loss in DTMR-Labeled RGCs Induced by IOP Elevation: To
corroborate the ocular hypertension-induced loss of cells in
the GCL, DTMR-labeled RGC counts were performed on
retina flatmounts derived from eyes in which the IOP was
elevated to 45 mmHg for 7 h. Figure 4A shows representative
images of retinas at different time points, from 3 days to 28
days, after a 7 h, 45 mmHg IOP elevation. It is clear from these
images that progressive RGC loss was obvious after the insult.
Quantitative analysis of this information is presented in Figure
4B. Thus, the density of DTMR-labeled RGC in the control
Figure 1. Intraocular pressure (IOP) elevation using the suture-pulley technique. A: Relationship of rat IOP and weights attached to the ends
of the suture. The IOP was measured for 60 min after the indicated weights were attached. Each symbol represents mean±SEM (n=6). *:
p<0.001 versus baseline using a one-way ANOVA and a Dunnett’s test. B: Effect of using 15 g weight on rat IOP. The weight was applied
starting at Time 0 and was maintained for 7 h for anesthetized rats. Each symbol represents mean±SEM (n=31 from Time 0 to 360 min, n=17
from 360 min to 420 min). *: p<0.001 versus baseline using a one-way ANOVA and a Dunnett’s test.
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867retinas was 1388±71/mm2. Three days after IOP elevation, its
density decreased, though not to the statistically significant
1291±103/mm2 (n=8, p>0.05). The RGC densities continued
to  decline.  On  Day  7,  RGC  density  was  1203±71/mm2
(p<0.05). On Day 14, it was 1031±37/mm2 (p<0.001). On Day
21, it was 833±63/mm2 (p<0.001). Finally, on Day 28, it was
671±53/mm2 (p<0.001). Compared to the control group, these
changes correspond to a 7%, 13%, 27%, 40%, and 52% RGC
loss on Days 3, 7, 14, 21, and 28, respectively.
IOP Elevation and electroretinography: To evaluate if the
IOP  elevation  of  45  mmHg  for  7  h  affected  outer  retina
functions, ERG was performed on insulted animals on Days
2, 6, 13, 20, and 27. Table 1 shows the amplitudes of A- and
B-waves were not significantly affected compared to their
respective baseline values (p>0.05). These findings suggest
the  outer  retina  was  not  functionally  damaged  by  this
procedure, which confirms the morphological findings shown
in Figure 3.
Figure 2. Time-dependent histological changes of rat optic nerves (ONs) induced by ocular hypertension (45 mmHg). Evaluation was
performed four weeks after the injury. A: Representative images of cross-sections of ONs from rats treated with 0 (control), 1, 2, 3, 4, 5, 6,
or 7 h of elevated intraocular pressure (IOP; 45 mmHg). In the control, which was subjected to 1–4 h of pressure, there was no identifiable
axonal swelling or damage or gliosis in the ON. When the duration of ocular hypertension was 5 h or longer, there was apparent axonal damage
(darkly stained axons) and swelling, and gliosis (lightly stained) became obvious. B: Higher magnification images of an ON from a control
rat and one that had elevated IOP for 5 h, showing axonal damage. C: Semi-quantitative analysis of pressure-induced ON damage using the
Optic Nerve Damage Score (ONDS). Each symbol represents mean±SEM (n=8). *p<0.001 versus the control group using a one-way ANOVA
and a Dunnett’s test.
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868Figure 3. Time-dependent morphological changes of the rat retina induced by ocular hypertension (IOP=45 mmHg). A: Representative images
of retina cross-sections from animals with 5, 6, or 7 h of induced ocular hypertension. The sections were stained with hematoxylin and eosin
and the thicknesses of various retinal layers and cell densities in the ganglion cell layer (GCL) were measured. Untreated eyes served as
controls. Thicknesses of the overall retina [OLM-ILM] (B), inner retinal layer [IPL-ILM] (C), ONL (D), OPL (E), INL (F), and cell density
in the GCL (G) were quantified and are shown. Bars represent mean±SEM *: p<0.001 versus control using a one-way ANOVA and a Dunnett’s
test. GCL: ganglion cell layer; ILM: inner limiting membrane; INL: inner nuclear layer; IPL: inner plexiform layer; OLM: outer limiting
membrane; ONL: outer nuclear layer; OPL: outer plexiform layer.
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869Figure 4. Effect of ocular hypertension (45 mmHg for 7 h) and RGC loss over 28 days. DTMR-labeled retinal ganglion cell (RGC) density
was examined at designated time points after IOP elevation. A: Representative 40× images from the central retina, showing a time-dependent
loss of RGC. B: Quantitative comparison of RGC densities between a naïve rat (Time 0) and different days after ocular hypertension (45 mmHg
for 7 h). Symbols represent mean±SEM (n=6). #: p<0.05 versus control using a one-way ANOVA and a Dunnett’s test. *: p<0.001 versus
control using a one-way ANOVA and a Dunnett’s test.
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870Protection by JNK Inhibitor SP600125: To investigate the
potential neuroprotective effect of the JNK inhibitor against
45 mmHg ocular hypertension-induced injuries in the retina,
a duration of 7 h was chosen because it produced the most
severe damage of the conditions tested. In this study, three
doses of SP600125 were tested (1.5, 5, and 15 mg/kg, i.p.). At
the highest dose (15 mg/kg), SP600125 significantly reversed
changes  of  retinal  layer  thickness  produced  by  ocular
hypertension. For example, the overall retinal thickness in the
SP600125-treated  ocular  hypertensive  eyes  was
201.5±9.1  µm  (n=4),  which  was  significantly  (p<0.001)
thicker than that of the vehicle-treated ocular hypertensive
eyes (170.9±8.2; n=5). However, it was not different from that
of the naïve, ocular normotensive eyes (207.1±4.40; n=19;
Figure  5A,B).  The  thickness  of  the  inner  retina  in  the
SP600125-treated ocular hypertensive eyes was 80.8±3.7 µm
(n=4), which was significantly (p<0.001) thicker than that of
the vehicle-treated ocular hypertensive eyes (60.0±3.8, n=5).
However, it was not different from that of the naïve, ocular
normotensive  eyes  (84.8±1.36,  n=19;  Figure  5A,C).
Similarly, cell density in the GCL also reflected the protective
effect  of  the  compound.  The  GCL  cell  density  in  the
SP600125-treated  ocular  hypertensive  eyes  was  12.5±0.7
cells/300 µm (n=4), which was significantly higher (p<0.001)
than  that  of  the  vehicle-treated  ocular  hypertensive  eyes
(6.1±0.8, n=5). However, it was not different from that of the
naïve, ocular normotensive eyes (12.7±0.24, n=19; Figure
5A,G). At a lower concentration (5 mg/kg), SP600125 also
significantly increased cell density in the GCL (p<0.001). At
1.5 mg/kg, the compound did not affect any of the parameters.
Ocular  hypertension,  with  or  without  treatment,  did  not
significantly affect the thickness of the ONL, OPL, or INL
(Figure 5A,D-F).
To attempt to obtain a more accurate assessment of the
effects of ocular hypertension with or without SP600125 on
RGC  survival,  retina  flatmounts  from  treated  eyes  were
immunolabeled with antibody to Brn-3a, a specific marker for
RGCs  [21].  The  labeled  RGCs  of  one  central  and  one
peripheral  field  (40×  magnification;  area  of  each
field=0.092 mm2) from each quadrant were counted manually.
The counts from the four central fields of each retina were
averaged  and  the  mean  RGC  density  (cells/mm2)  was
calculated and reported for each retina. Likewise, the counts
from the four peripheral fields of each retina were assessed
and  reported  in  an  identical  fashion.  Figure  6A,B  show
representative  images  of  labeled  RGCs  in  central  and
peripheral  fields  of  control  and  ocular  hypertensive  rats
treated with intraperitoneal administration of the vehicle or
SP600125. Figure 6C,D summarize the quantification of RGC
densities under various conditions. In the central retina of
control eyes, there were 3542±85 RGCs/mm2 (n=9). Ocular
hypertension for 7 h reduced RGC survival and significantly
(p<0.001) lowered the RGC density to 1481±99 cells/mm2
(n=4), whereas treatment with SP600125 partially protected
against this insult and significantly (p<0.001) increased the
RGC density to 3044±97 cells/mm2 (n=5). Similar findings
were observed for the peripheral retina. Ocular hypertension
significantly diminished the RGC density to 1496±152 cells/
mm2 (n=4), compared to that of the control retinas, which was
3225±108 cells/mm2 (n=9, p<0.001). SP600125 significantly
(p<0.001) increased the RGC density to 2282±88 cells/mm2
(n=5).
DISCUSSION
In this report, we show that the suture-pulley model elevates
IOP dependent on the standard weight (in grams) applied to
the eye. Specifically, when the standard weight increases, IOP
increases  correspondingly.  Prolonged  elevation  of  IOP  to
45 mmHg for 5–7 h induced irreversible damage to the RGC
—as indicated by a significant loss of RGC, thinning of the
inner retinal layer, and optic neuropathy—without affecting
the outer retina. These effects are similar to those observed in
acute  angle-closure  glaucoma  attacks.  We  further
demonstrated  that  systemic  administration  of  the  JNK
inhibitor  SP600125  significantly  protected  against  ocular
hypertensive-induced RGC loss.
As previously reported [13], the current suture-pulley
method that gently compresses the eye to increase IOP is not
invasive and is technically very easy to implement. It is not
an  excessively  delicate  procedure,  so  sophisticated  and
lengthy training is not required. Prior to the current study, we
used this technique to induce transient retinal ischemia using
a 35 g weight, as indicated by blanching of the retina during
the procedure, and the diminished amplitudes of A- and B-
TABLE 1. EFFECT OF IOP ELEVATION (45 MMHG FOR 7 H) ON ERG A- AND B-WAVE AMPLITUDES (MEAN±SEM; N=6)
Time points A-wave amplitude (µV) B-wave amplitude (µV)
Baseline 453±19 1180±79
Day 2 467±21 1089±83
Day 6 471±11 1293±113
Day 13 415±39 1228±32
Day 20 419±79 1057±91
Day 27 398±63 1001±109
            Note: Data are mean±SEM (n=6). No statistical significance among the groups was detected by One-Way ANOVA.
Molecular Vision 2011; 17:864-875 <http://www.molvis.org/molvis/v17/a97> © 2011 Molecular Vision
871Figure 5. Dose-dependent protective effect of SP600125 against retina changes induced by intraocular pressure (IOP) elevation (45 mmHg)
for 7 h. A: Representative images of hematoxylin and eosin-stained retinal cross-sections of eyes subjected to the different treatments.
Thicknesses of the overall retina (B), inner retinal layer (C), ONL (D), OPL (E), INL (F), and cell density in the GCL (G) were quantified
and are shown. Bars represent mean±SEM *: p<0.001 versus the “Control + Vehicle” group using a one-way ANOVA and a Dunnett’s test.
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872waves [13]. Subsequently, we found that by decreasing the
weight, we can reproducibly generate moderate elevation of
IOP  without  affecting  retinal  blood  flow.  Therefore,  this
method is useful for studying acute ocular hypertension, such
as acute PACG attacks. We targeted IOP at 45 mmHg to
function as a glaucomatous insult to RGCs because various
studies determined that 30–50 mmHg IOP is the threshold of
selective damage to RGCs. This is further corroborated since
an IOP of 50 mmHg has been observed to selectively impair
optic nerve oxygenation without affecting choroidal supply
(outer  retina)  [25].  However,  most  of  these  insults  only
produced a transient, reversible functional change of the inner
retina or RGC, without affecting the long-term function or
survival of RGCs. Our findings indicate that increasing the
Figure 6. Protective effect of SP600125 on ocular hypertension-induced changes in retinal ganglion cell (RGC) density in the rat retina; “IOP
elevation” corresponds to raising the intraocular pressure (IOP) to 45 mmHg for 7 h. A, B: Representative 40× images from the central (A)
or peripheral (B) fields. The left-hand images are from control rats. The middle images are from IOP elevation + vehicle-treated rats. The
right-hand images are from IOP elevation + SP600125 treated rats. Densities of RGC in the central (C) and peripheral (D) fields of the different
study groups were quantified. Data are expressed as mean±SEM. Statistical significance was evaluated using a one-way ANOVA and a
Bonferroni test.
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873duration of 45 mmHg IOP to 5–7 h was sufficient to produce
irreversible damage to ON axons and RGCs, without injuring
the outer layers of the retina. The decrease in ON axons and
RGC density correlated with the duration of hypertension, as
indicated  by  the  ONDS,  GCL  cell  density,  retinal  layer
thickness, and DTMR-labeled RGC density studies. Based on
these results, we further selected a 7 h duration of hypertension
as our standard study protocol because it caused the maximum
damage within a practical time frame for an experimental
procedure.  The  pressure-induced  RGC  damage  was  not
immediately apparent after the insult; the loss of RGC as
assessed by DTMR-labeled cells in the retina became more
severe  as  the  post-procedure  time  lengthened,  such  that
approximately 50% of RGCs vanished 28 days later.
The  prolonged  application  of  moderate  ocular
hypertension allows investigation of the dynamics of initial
morphological,  molecular,  and  functional  changes  under
controlled conditions, which provides insight into the effects
of  moderate  short-term  elevated  IOP  on  RGCs  and  the
possible underlying mechanisms of RGC damage during the
early stages of glaucoma.
Many mechanisms could be responsible for RGC injury
induced by elevated IOP. Apoptosis was observed in the GCL
following IOP elevation [26]. The neurodegenerative effect
demonstrated by this method was likely the result of apoptosis
in RGCs [22]. At the present time, it is not clear where the
initial  primary  injury  site  is.  The  excessive  pressure  may
damage the RGC soma directly, but it can also initiate damage
by compressing the RGC axons, which may interfere with
intra-axonal  transport  of  pro-survival  molecules,  such  as
trophic factors. Alternatively, pressure-induced compression
of the retinal blood vessels can cause mild ischemia in certain
retinal tissues [12-14]. For example, the inner retina, which
has a high metabolic demand and the blood flow of which is
supplied by the central retinal artery, may be more vulnerable
to metabolic stress induced by the insult when compared to
the outer retina [12-14].
There is a well recognized need to develop glaucoma
therapies  that  target  mechanisms  other  than  IOP  control.
Protecting the retina from glaucoma injury is as important as
controlling  IOP.  For  example,  JNK  inhibitors  such  as
SP600125 have been shown to reduce neuronal cell death in
the brain as well as the retina. Such inhibitors protect against
rat  hippocampal  CA1  cell  loss  caused  by  transient  brain
ischemia/reperfusion [19,20]. SP600125 also protects against
excitotoxicity-induced apoptosis of RGCs [19]. In the present
study, we found that SP600125 significantly preserved RGC
density in rats compared to the vehicle-treated group after 7 h
of  IOP  elevation.  The  results  of  this  study  suggest  that
SP600125  interferes  with  the  JNK  cascade  of  events
responsible for RGC apoptosis and supports RGC survival.
In summary, the results of this study demonstrate that the
progressive loss of RGC over the course of weeks and the
decrease in inner retinal thickness are a direct response to the
prolonged duration of applying 45 mmHg IOP to the rat eye.
SP600125 protects RGCs from this insult, indicating that JNK
activation is a key signaling component that contributes to
RGC loss in this model and may be a potential neuroprotective
target for the treatment of PACG attacks or other forms of
glaucomatous optic neuropathy and retinopathy.
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